KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Clinical trial NCT07260812 · RECRUITING

Trial details

NCT number: NCT07260812
Sponsor: TCRx Therapeutics Co.Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Diffuse Large B Cell Lymphoma (DLBCL)

Start date: 2025-09-01
Primary completion: 2028-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.